iniparib
Term · Oncology and biomedicine · MLC-T-ONC-004330
A substance being studied in the treatment of some types of cancer. Iniparib may kill cancer cells. Also called BSI-201.
A small molecule iodobenzamide with potential cytotoxic and antineoplastic activities. Although the mechanism of action is unknown, iniparib appears to be cytotoxic in cells with DNA alterations or DNA damage, like that found in tumor cells with mutations in the ataxia telangiectasia mutated (ATM) gene. ATM encodes a serine/threonine protein kinase and mutations of the gene are associated with ataxia telangiectasia and contribute to certain cancers such as T-cell acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia and B-cell non-Hodgkin lymphomas.
| Identifier | MLC-T-ONC-004330 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | BSI-201 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-004330",
"term": "iniparib",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied in the treatment of some types of cancer. Iniparib may kill cancer cells. Also called BSI-201.",
"A small molecule iodobenzamide with potential cytotoxic and antineoplastic activities. Although the mechanism of action is unknown, iniparib appears to be cytotoxic in cells with DNA alterations or DNA damage, like that found in tumor cells with mutations in the ataxia telangiectasia mutated (ATM) gene. ATM encodes a serine/threonine protein kinase and mutations of the gene are associated with ataxia telangiectasia and contribute to certain cancers such as T-cell acute lymphoblastic leukemia, B-cell chronic lymphocytic leukemia and B-cell non-Hodgkin lymphomas."
],
"synonyms": [
"BSI-201"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/iniparib/"
}
Record 9,275 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.